Triage for selection to colonoscopy?

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

DOI

  • Mathias Mertz-Petersen, Center for Surgical Research, Department of Surgical Gastroenterology, Hvidovre Hospital, Hvidovre, Denmark.
  • ,
  • Thomas B Piper, Center for Surgical Research, Department of Surgical Gastroenterology, Hvidovre Hospital, Hvidovre, Denmark.
  • ,
  • Jakob Kleif, Center for Surgical Research, Department of Surgical Gastroenterology, Hvidovre Hospital, Hvidovre, Denmark.
  • ,
  • Linnea Ferm, Center for Surgical Research, Department of Surgical Gastroenterology, Hvidovre Hospital, Hvidovre, Denmark.
  • ,
  • Ib Jarle Christensen, Center for Surgical Research, Department of Surgical Gastroenterology, Hvidovre Hospital, Hvidovre, Denmark.
  • ,
  • Hans J Nielsen, Københavns Universitet
  • ,
  • Erland Jørn Erlandsen
  • ,
  • Claus Lindbjerg Andersen (Medlem af forfattersamarbejde)
  • Danish Collaborative Group on Early Detection of Colorectal Neoplasia

Implementation of population screening for colorectal cancer by direct colonoscopy or follow-up colonoscopy after a positive fecal blood test has challenged the overall capacity of bowel examinations. Certain countries are facing serious colonoscopy capacity constraints, which have led to waiting lists and long-time latency of follow-up examinations. Various options for improvement are considered, including increased cut-off values of the fecal blood tests. Results from major clinical studies of blood-based, cancer-associated biomarkers have led to focus, however, on a triage concept for improved selection to colonoscopy. The triage test may include subject age, concentration of hemoglobin in a feces test and a combination of certain blood-based cancer associated biomarkers. Recent results have indicated that triage may reduce the requirements for colonoscopy by around 30%. Such results may be advantageous for the capacity, the heath budgets and in particular, the subjects, who do not need an unnecessary, unpleasant and risk-associated bowel examination.

OriginalsprogEngelsk
TidsskriftEuropean Journal of Surgical Oncology
Vol/bind44
Nummer10
Sider (fra-til)1539-1541
Antal sider3
ISSN0748-7983
DOI
StatusUdgivet - okt. 2018

Bibliografisk note

Copyright © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Se relationer på Aarhus Universitet Citationsformater

ID: 137739237